The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

Astra has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new ...

Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...

Vietnamese Prime Minister Pham Minh Chinh held working sessions with leading Swedish corporations, including Ericsson, H&M, SYRE, and AstraZeneca in Stockholm on June 13 to foster their investment and ...

AstraZeneca inks strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research: Cambridge, UK Saturday, June 14, 2025, 09:00 Hrs [IST] AstraZeneca has entered a ...

Quantum computing stocks are high-risk, high-reward plays, where the tech still feels futuristic, but the potential upside ...

The guidelines include disease-specific recommendations screening, monitoring disease progression, and treatment options for ILD.

Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

CINCINNATI ( Cincinnati Business Courier) - Backed by big money and aggressive plans to manufacture cutting-edge gene and ...

When the children of my friends and clients announce they are getting married, it is not the wedding venue or dress that is ...

Beyond the discount and dividend, ETO’s 12.3% annualized return on NAV (orange line above) should also be a shiny lure for ...